Antithrombogenic articles

• US 4,326,532 A
• Filed: 10/06/1980
• Issued: 04/27/1982
• Est. Priority Date: 10/06/1980
• Status: Expired due to Term

• Current Assignee: 3M Company
• Original Assignee: 3M Company
• Inventors: Hammar, Walton J.
• Primary Examiner(s): Rosenbaum, C. Fred
• Application Number:
  US06/194,576
• Time in Patent Office: 568 Days
• Field of Search: 128/1 R, 128/156, 128/213 A, 128/214 B, 128/214 D, 128/325, 128/348-350, 128/DIG. 22, 210/321.3, 210/500.1, 210/500.2, 260/9, 424/16, 424/183, 428/411, 428/420, 428/423.1, 428/473, 427/339, 427/415, 427/419.7
• US Class Current: 604/266
• CPC Class Codes: A61L 27/34 Macromolecular materials
• CPC Class Codes: A61L 33/0029 using an intermediate layer of polymer
• CPC Class Codes: C08L 5/08 Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
• CPC Class Codes: Y10T 428/31504 Composite [nonstructural laminate]

Abstract

A medical article having a layered antithrombogenic surface is useful as a polymeric implant. The article comprises a polymeric substrate coated with chitosan to which is appended an antithrombotic agent. A process for rendering the surface of a polymer antithrombogenic is disclosed.

Claims

1. A medical article of manufacture having a layered nonthrombogenic surface comprising:

a natural or synthetic polymeric substrate,

a chitosan coating bonded to said polymeric substrate, and

an antithrombotic agent bonded to said chitosan coating.

2. The article according to claim 1 wherein said antithrombotic agent is a sulfated polysaccharide, prostaglandin, or albumin.

3. The article according to claim 2 wherein said antithrombotic agent is heparin.

4. The article according to claim 1 wherein said polymeric substrate is a catheter.

5. The article according to claim 1 wherein said polymeric substrate is a kidney dialysis membrane.

6. The article according to claim 1 wherein said polymeric substrate is silicone rubber, polyethylene, polyvinyl chloride, polyurethane, polypropylene, teflon, or cellulose.

7. The article according to claim 1 wherein the level of chitosan in said chitosan coating is in the range of about 0.01 to 100 mg/cm².

8. The article according to claim 7 wherein said level of chitosan in the chitosan coating is about 0.05 to 1.0 mg/cm².

9. The article according to claim 3 wherein the level of heparin is in the range of about 0.1 to 7.0 I.U.'"'"'s/cm².

10. A process for rendering the surface of a polymer antithrombogenic comprising the steps:

(a) priming said polymeric surface so as to render it receptive to the coating of a chitosan salt thereon,

(b) coating said chitosan salt from acid solution onto said polymeric surface,

(c) reacting the resulting chitosan salt coated polymeric surface with base to convert said chitosan salt to free chitosan, and

(d) bonding an antithrombogenic agent to said chitosan coated polymeric article.

11. A process according to claim 10 further comprising bonding said chitosan coated polymeric article with said antithrombogenic agent in the presence of a chemically effective amount of a boron hydride.

12. A process according to claim 11 wherein said boron hydride is NaBH₄ or NaCNBH₃.

13. A process according to claim 10 further comprising treating the resulting antithrombogenic article with glutaraldehyde to crosslink the chitosan and antithrombogenic agent.

14. The process according to claim 10 wherein said chitosan coating is covalently bonded to said polymeric substrate.

15. The process according to claim 10 wherein said chitosan coating is ionically bonded to said polymeric substrate.

16. The process according to claim 10 wherein said antithrombotic agent is covalently bonded to said chitosan coating.

17. The process according to claim 10 wherein said antithrombotic agent is ionically bonded to said chitosan coating.

18. An article of manufacture comprising a self-supporting film of chitosan with an antithrombotic agent bonded thereto.